Press release
Survival Motor Neuron Protein (Component of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review and Healthcare eEport, H2 2017
Market Research Hub
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246537
The According to the recently published report 'Survival Motor Neuron Protein - Pipeline Review, H2 2017'; Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes.
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Survival of motor neuron or survival motor neuron (SMN) is a protein encoded by the SMN1 and SMN2 genes. The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs). They play an important role in the splicing of cellular pre-mRNAs. They ensure the correct splicing of U12 intron-containing genes that is important for normal motor and proprioceptive neurons development. They are required for resolving RNA-DNA hybrids created by RNA polymerase II. They play a role in the metabolism of small nucleolar ribonucleoprotein.
The report 'Survival Motor Neuron Protein - Pipeline Review, H2 2017' outlays comprehensive information on the Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews key players involved in Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Pre-Registration, Phase II and Preclinical stages are 1, 3 and 8 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 4 and 1 molecules, respectively. Report covers products from therapy areas Central Nervous System and Respiratory which include indications Spinal Muscular Atrophy (SMA) and Cystic Fibrosis.
Scope
- The report provides a snapshot of the global therapeutic landscape for Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2)
- The report reviews Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) targeted therapeutics and enlists all their major and minor projects
- The report assesses Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) targeted therapeutics
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Read Full Report with TOC: http://www.marketresearchhub.com/report/survival-motor-neuron-protein-component-of-gems-1-or-gemin-1-or-smn1-or-smn2-pipeline-review-h2-2017-report.html
Table of Contents:
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Overview 6
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Therapeutics Development 7
Products under Development by Stage of Development 7
Products under Development by Therapy Area 8
Products under Development by Indication 9
Products under Development by Companies 10
Products under Development by Universities/Institutes 12
Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1246537
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: www.marketresearchhub.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Survival Motor Neuron Protein (Component of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review and Healthcare eEport, H2 2017 here
News-ID: 636401 • Views: …
More Releases from Market Research Hub
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the…
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section…
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
More Releases for SMN
Revolutionary Gene Therapies Transform the Spinal Muscular Atrophy Treatment Lan …
The spinal muscular atrophy (SMA) drugs market was valued at approximately USD 4.7 billion in 2023 and is anticipated to reach USD 14.3 billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033.
The spinal muscular atrophy (SMA) pharmaceutical sector has experienced unprecedented transformation over the past decade, evolving from a landscape with virtually no treatment options to one featuring groundbreaking therapeutic innovations that are fundamentally changing patient…
South Korea Spinal Muscular Atrophy (SMA) Therapeutics Market 2023 Share, Size, …
The South Korea Spinal Muscular Atrophy (SMA) Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global South Korea Spinal Muscular Atrophy (SMA) Therapeutics market. This report explores all the key factors…
South Korea Spinal Muscular Atrophy (SMA) Therapeutics Market Business Scenario …
The South Korea Spinal Muscular Atrophy (SMA) Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global South Korea Spinal Muscular Atrophy (SMA) Therapeutics market. This report explores all the key factors…
Mixing Nozzles Market | Global Trends Forecast to 2028
According to Precision Business Insights (PBI) latest report, the mixing nozzles market is expected to be worth USD 3,422.0 billion in 2022, growing at a 4.1% CAGR from 2022 to 2028. Flow or knit lines, uneven part weight, or cavity distribution can occur if a combination does not reach a homogenized melt temperature. With varied elements and melting temperatures, the correct mixing nozzle can help reduce temperature differences. Back-pressure is…
Mixing Nozzles Market SWOT Analysis, Key Development And Forecasts Till 2028
Precision Business Insights published a research report on "Mixing Nozzles Market: By Type (SMN, SMF, Others), By Application (Injection Molding, Others) - Global/Region/Country Forecast to 2028"
A device used to break the liquid flow together into spray pattern is a mixing nozzle. Despite the nozzles' apparent simplicity, there are a plethora of different products available to meet the diverse needs of many industries when spraying various fluids as well as liquids.…
Spinal Muscular Atrophy Market Revenue Status And Outlook 2015-2023 Detailed In …
Spinal muscular atrophy or SMA is a genetic disorder that affects the nervous system, impairing voluntary muscle movement. It is a hereditary autosomal recessive disease and causes mortality in children. Earlier onset of SMA makes the impact greater, damaging the motor function of the child to a larger extent. Children who show symptoms at birth or infancy have type 1 SMA, which leads to minimal motor skill functioning. However, the…
